Application of iPS cell technology to cancer epigenome study: Uncovering the mechanism of cell status conversion for drug resistance in tumor

作者: Yutaka Matsuda , Katsunori Semi , Yasuhiro Yamada

DOI: 10.1111/PIN.12180

关键词:

摘要: Recent studies imply that cancer cells possess the ability to reversibly change their properties between a drug sensitive state and resistant accompanied by epigenetic changes. This evidence indicates better understanding of epigenetics is important for efficient therapies. Nevertheless, it had been difficult deeply examine mechanisms because lack tools actively modify coordinated events. In this stagnant situation, reprogramming technology established Yamanaka coworkers have shed new light. The novel has made possible researchers artificially introduce remodeling into somatic cells. Accordingly, we might be able use as tool reorganization. In review, idea cell interconversion in attributable altered regulations. We then depict modifications observed during process give some examples difficulty reprogramming. Finally, discuss how can translate refractoriness uncovering unique regulations cells, which applicable eventually development therapeutics against

参考文章(72)
Astrid Hagelkruys, Anna Sawicka, Magdalena Rennmayr, Christian Seiser, The Biology of HDAC in Cancer: The Nuclear and Epigenetic Components Handbook of experimental pharmacology. ,vol. 206, pp. 13- 37 ,(2011) , 10.1007/978-3-642-21631-2_2
T. Wakayama, A. C. F. Perry, M. Zuccotti, K. R. Johnson, R. Yanagimachi, Full-term development of mice from enucleated oocytes injected with cumulus cell nuclei Nature. ,vol. 394, pp. 369- 374 ,(1998) , 10.1038/28615
Richard Poulsom, Walter F Bodmer, George Elia, Annie On-On Chan, Wai-Man Wong, Sean L Preston, Nicholas A Wright, Rosemary Jeffery, Ian P Tomlinson, Nikki Mandir, Marco Novelli, Robert A Goodlad, Bottom-up Histogenesis of Colorectal Adenomas Origin in the Monocryptal Adenoma and Initial Expansion by Crypt Fission Cancer Research. ,vol. 63, pp. 3819- 3825 ,(2003)
T. Hikichi, R. Matoba, T. Ikeda, A. Watanabe, T. Yamamoto, S. Yoshitake, M. Tamura-Nakano, T. Kimura, M. Kamon, M. Shimura, K. Kawakami, A. Okuda, H. Okochi, T. Inoue, A. Suzuki, S. Masui, Transcription factors interfering with dedifferentiation induce cell type-specific transcriptional profiles Proceedings of the National Academy of Sciences of the United States of America. ,vol. 110, pp. 6412- 6417 ,(2013) , 10.1073/PNAS.1220200110
Bradley E. Bernstein, Tarjei S. Mikkelsen, Xiaohui Xie, Michael Kamal, Dana J. Huebert, James Cuff, Ben Fry, Alex Meissner, Marius Wernig, Kathrin Plath, Rudolf Jaenisch, Alexandre Wagschal, Robert Feil, Stuart L. Schreiber, Eric S. Lander, A Bivalent Chromatin Structure Marks Key Developmental Genes in Embryonic Stem Cells Cell. ,vol. 125, pp. 315- 326 ,(2006) , 10.1016/J.CELL.2006.02.041
H Yang, Y Liu, F Bai, JY Zhang, SH Ma, J Liu, ZD Xu, HG Zhu, ZQ Ling, D Ye, KL Guan, Y Xiong, None, Tumor development is associated with decrease of TET gene expression and 5-methylcytosine hydroxylation Oncogene. ,vol. 32, pp. 663- 669 ,(2013) , 10.1038/ONC.2012.67
Ronghui Li, Jialiang Liang, Su Ni, Ting Zhou, Xiaobing Qing, Huapeng Li, Wenzhi He, Jiekai Chen, Feng Li, Qiang Zhuang, Baoming Qin, Jianyong Xu, Wen Li, Jiayin Yang, Yi Gan, Dajiang Qin, Shipeng Feng, Hong Song, Dongshan Yang, Biliang Zhang, Lingwen Zeng, Liangxue Lai, Miguel Angel Esteban, Duanqing Pei, A Mesenchymal-to-Epithelial Transition Initiates and Is Required for the Nuclear Reprogramming of Mouse Fibroblasts Cell Stem Cell. ,vol. 7, pp. 51- 63 ,(2010) , 10.1016/J.STEM.2010.04.014
Abdenour Soufi, Greg Donahue, Kenneth S. Zaret, Facilitators and Impediments of the Pluripotency Reprogramming Factors' Initial Engagement with the Genome Cell. ,vol. 151, pp. 994- 1004 ,(2012) , 10.1016/J.CELL.2012.09.045
Sevin Turcan, Daniel Rohle, Anuj Goenka, Logan A. Walsh, Fang Fang, Emrullah Yilmaz, Carl Campos, Armida W. M. Fabius, Chao Lu, Patrick S. Ward, Craig B. Thompson, Andrew Kaufman, Olga Guryanova, Ross Levine, Adriana Heguy, Agnes Viale, Luc G. T. Morris, Jason T. Huse, Ingo K. Mellinghoff, Timothy A. Chan, IDH1 mutation is sufficient to establish the glioma hypermethylator phenotype Nature. ,vol. 483, pp. 479- 483 ,(2012) , 10.1038/NATURE10866